Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Sensus Healthcare, Inc. (NASDAQ:SRTS) President and General Counsel Michael Sardano reported purchasing 1,000 shares of common stock on August 13, 2025. The shares were bought at a price of $3.37, totaling $3,370. The insider purchase comes as the stock has declined over 36% in the past week, with analysts maintaining price targets between $6 and $10. According to InvestingPro analysis, the company appears undervalued at current levels.
Following the transaction, Sardano directly owns 116,839 shares of Sensus Healthcare. The $55.4M market cap company maintains strong financial health with more cash than debt and a robust current ratio of 8.14. Discover more insights about SRTS and 1,400+ other stocks with InvestingPro’s comprehensive research reports.
In other recent news, Sensus Healthcare reported its Q2 2025 earnings, which fell short of market expectations. The company experienced a net loss, and its revenue declined significantly compared to the previous year. These disappointing financial results were a notable development for the company. The earnings report highlighted the challenges Sensus Healthcare is currently facing. There was no mention of any mergers or acquisitions in the recent updates. Analyst reactions to the earnings report have not been specified. Additionally, there were no upgrades or downgrades by analysts reported in the context provided. Investors may want to keep an eye on any future announcements from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.